Dexmedetomidine may reduce the risk of acute kidney injury development in critically ill patients during colistin therapy.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy（2023）

引用 0|浏览18

暂无评分

摘要

In respect to these findings, dexmedetomidine may provide protection against AKI during colistin therapy in critically ill patients.

查看译文

关键词

Acute renal failure,Colistin,Critical care,Dexmedetomidine,Infection

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要